RoslinCT

Edinburgh, UK · Hopkinton, MA
Find alternatives to RoslinCT for CAR-T →
Program data pending ClinicalTrials.gov matching · Last scored 2026-11-12
79.3
Signal Score
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ✓ Press (3) ○ EMA GMP ✓ MHRA GMP (1) ✓ HC GMP (2)

Quick Facts: RoslinCT

Signal Score
79.3/100 (as of 2026-11-12)
Quality Compliance
96.8/100
Headquarters
Edinburgh, UK · Hopkinton, MA
Modalities
CAR-T, Cell Therapy, iPSC, Gene Editing
Active Programs
No ClinicalTrials.gov matches confirmed — 2 partnership signals in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About RoslinCT

Merged with Lykan Bioscience.

Signal Score & Pillar Breakdown

Quality Compliance 96.8
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-01-21)
MHRA GMP Certificates1 on record
Most Recent HC OutcomeCompliant · 2023-07-31
HC Attribution2 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 2 partnership announcements found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, iPSC, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 68.0
2 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Edinburgh, UK, Hopkinton, MA
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
StatusAvailable
2 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Edinburgh, UK, Hopkinton, MA
Press Signals3 articles (not scored)
2 manufacturing sites
Broad modality coverage (4 modalities)

RoslinCT FDA Inspection History

2025-01
NAI VAI OAI
Date Site Type 483 citations posted Classification
2025-01-21
ROSLIN CELL THERAPIES LIMITED
Edinburgh Facility-linked
Human Cellular, Tissue, and Gene Therapies Yes Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

RoslinCT FDA 483 Findings 3 observations · 2025-01-21 → 2025-01-21 ?

By subsystem

  • Documentation & Records 2 (66.7%)
  • Data Integrity 1 (33.3%)

By severity

  • 5 — Critical: 1
  • 2 — Minor: 2
  • Repeat observations: 0

Most severe findings

  • Critical (5) Data Integrity 2025-01-21 21 CFR 211.68(b)
    Computer control of master formula records

    "Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."

  • Minor (2) Documentation & Records 2025-01-21 21 CFR 211.113(b)
    Procedures for sterile drug products

    "Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed."

  • Minor (2) Documentation & Records 2025-01-21 21 CFR 211.22(d)
    Procedures not in writing, fully followed

    "The responsibilities and procedures applicable to the quality control unit are not fully followed."

RoslinCT MHRA GMP Compliance 1 certificates

2021-07
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK MIA(IMP) 45803 Insp IMP 45803/4883575-0018[I] ROSLINCT INSTITUTE FOR REGENERATION AND REPAIR NORTH EDINBURGH EH16 4UU 2021-07-27 COMPLIANT
Source: MHRA GMDP Database · Retrieved Nov 21, 2026

Hiring Activity 8 open roles Beta

From public job postings on RoslinCT's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
8
open roles
8
in manufacturing, quality, PD/MSAT, engineering or regulatory (100%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 1 taken down.
By function
Manufacturing & operations 4
Quality (QA / QC) 3
Engineering & facilities 1
By site
Edinburgh, United Kingdom profile site
4 mfg/ops · 2 QA/QC · 1 eng.
7
Dalkeith, United Kingdom
· 1 QA/QC
1
Latest postings
Quality Assurance Officer II Quality (QA / QC) · Dalkeith, United Kingdom · posted Nov 16, 2026
Process Support Specialist Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 16, 2026
Multi-Skilled Maintenance Technician Engineering & facilities · Edinburgh, United Kingdom /... · posted Nov 13, 2026
Cleaner - Part Time Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 12, 2026
Senior Quality Operations Manager Quality (QA / QC) · Edinburgh, United Kingdom · posted Nov 12, 2026
Process Support Team Lead Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 11, 2026
Manufacturing Technician - Commercial Manufacturing Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 10, 2026
Quality Control Supervisor - Analytical Quality (QA / QC) · Edinburgh, United Kingdom · posted Oct 7, 2026
Coverage: counted from RoslinCT's own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: roslinct.teamtailor.com · Checked Nov 20, 2026 · Tracking since Oct 26, 2026

Company Signals 3 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-10-06
RoslinCT lands £7.25M Scottish grant to digitise cell therapy manufacturing - Dealroom
RoslinCT lands £7.25M Scottish grant to digitise cell therapy manufacturing  Dealroom
partnership 2026-10-06
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing - Business Wire
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing  Business Wire
partnership 2026-10-06
RoslinCT Awarded Up To £7.25 Million Scottish Enterprise Grant For Digital Cell Therapy Manufacturing - Pulse 2.0
RoslinCT Awarded Up To £7.25 Million Scottish Enterprise Grant For Digital Cell Therapy Manufacturing  Pulse 2.0

Frequently Asked Questions About RoslinCT

How many FDA inspections does RoslinCT have on record?
CDMO Signal tracks 1 FDA inspection for RoslinCT, sourced from the FDA inspection database. See the full inspection history above.
Has RoslinCT received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for RoslinCT.
Does RoslinCT hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for RoslinCT.
What is RoslinCT's CDMO Signal Score?
RoslinCT has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating RoslinCT for a manufacturing program?
Use the free AI matchmaker to compare RoslinCT against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs → Gene Editing CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
GenScript
Piscataway, NJ / Nanjing, China
Signal Score: 64.0
CAR-T, Cell Therapy, Gene Editing
CTMC
Houston, TX
Signal Score: 63.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy

Compare RoslinCT with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on RoslinCT
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.